Michael Rada serves as a Principal Clinical Research Associate (CRA) at PPD, based in the Rockville, MD office, where he has honed his expertise in clinical management over the past seven years, particularly in the field of Infectious Diseases. His extensive experience encompasses a strong...
Michael Rada serves as a Principal Clinical Research Associate (CRA) at PPD, based in the Rockville, MD office, where he has honed his expertise in clinical management over the past seven years, particularly in the field of Infectious Diseases. His extensive experience encompasses a strong focus on HIV and Hepatitis C indications, where he has played a pivotal role in advancing clinical trials that aim to improve patient outcomes and enhance therapeutic strategies. Michael's passion for Infectious Diseases is not just professional; it borders on obsession, driving him to stay at the forefront of emerging research and innovative treatment options.
In his current role, Michael leads key projects that involve the management of complex clinical trials, ensuring adherence to ICH-GCP guidelines and regulatory submissions. His proficiency in Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) has been instrumental in streamlining data management processes, thereby enhancing the efficiency and accuracy of clinical data collection. Michael's comprehensive understanding of various therapeutic areas, coupled with his hands-on experience in oncology and other indications, allows him to approach challenges with a multifaceted perspective.
Michael's commitment to excellence in clinical research is evident in his collaborative work with cross-functional teams, where he leverages his skills in clinical data management to drive project success. His ability to navigate the intricacies of clinical trials, combined with his deep-seated knowledge of Infectious Diseases, positions him as a valuable asset to PPD and the broader clinical research community. As he continues to push the boundaries of research in this critical field, Michael remains dedicated to making a meaningful impact on public health through innovative clinical solutions.